The need for caution in considering the diagnostic utility of antibasal ganglia antibodies in movement disorders

Archives of Disease in Childhood

Volumn 89, Issue 7, 2004, Pages 595-597

  Singer, H S ^a,b   Hong, J J ^a   Rippel, C A ^a   Pardo, C A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASAL GANGLIA ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY TITER; AUTOIMMUNE DISEASE; CHILD; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE; LABORATORY TEST; MOLECULAR MIMICRY; MOTOR DYSFUNCTION; NONHUMAN; NOTE; PRIORITY JOURNAL; SCREENING TEST; STREPTOCOCCUS GROUP A; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; AUTOIMMUNITY; BASAL GANGLIA; BIOLOGICAL MARKERS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MOVEMENT DISORDERS; RATS; STREPTOCOCCAL INFECTIONS;

EID: 3042721498     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2003.046847     Document Type: Note

References (14)

1. Church AJ, Dale RC, Giovannoni G. Anti-basal ganglia antibodies: a possible diagnostic utility in idiopathic movement disorders? Arch Dis Child 2004;89:611-4.
2. Singer HS, Loiselle C. PANDAS: a commentary. J Psychosom Res 2003;55:31-9.
3. Kurlan R. Tourette's syndrome and 'PANDAS': will the relation bear out? Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Neurology 1998;50:1530-4.
4. Kaplan EL, Gerber MA. Group A, group C, and group G beta hemolytic streptococcal infections. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases, Vol. 1. Philadelphia: W. B. Saunders, 1998:1076-88.
5. Archelos JJ, Hartung HP. Pathogenetic role of autoantibodies in neurological diseases. Trends Neurosci 2000;23:317-27.
6. Church AJ, Cardoso F, Dale RC, et al. Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology 2002;59:227-31.
7. Singer HS, Loiselle CR, Lee O, et al. Anti-basal ganglia antibody abnormalities in Sydenham chorea. J Neuroimmunol 2003;136:154-61.
8. Singer HS, Loiselle CR, Lee O, et al. Anti-basal ganglia antibody abnormalities in PANDAS. Mov Disord 2004;19:406-15.
9. Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998;155:264-71.
10. Singer HS, Giuliano JD, Hansen BH, et al. Antibodies against human putamen in children with Tourette syndrome. Neurology 1998;50:1618-24.
11. Bornstein NM, Aronovich B, Korczyn AD, et al. Antibodies to brain antigens following stroke. Neurology 2001;56:529-30.
12. Hallett JJ, Harling-Berg CJ, Knopf PM, et al. Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction. J Neuroimmunol 2000;111:195-202.
13. Taylor JR, Morshed SA, Parveen S, et al. An animal model of Tourette's syndrome. Am J Psychiatry 2002;159:657-60.
14. Loiselle CR, Lee O, Moran TH, et al. Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes. Mov Disord 2004;19:390-6.